User login

7th EADO Congress

20 июн 2011 - 14:00
23 июн 2011 - 12:10
Europe/Paris

Седьмой конгресс Европейской ассоциации дерматоонкологии (EADO) состоится в Нанте, Франция, 20-23 июня 2011 года.
Официальный сайт конгресса

Официальная программа конгресса


Monday, 20 June 2011

14:00-15:30 | Plenary session : Best of new aspects in the field of...
Sponsored by Roche
Chairs: Jean-Jacques Grob (France), Claus Garbe (Germany), Bernard Guillot (France)

  • Epithelial skin carcinomas
    Nicole Basset-Seguin (France)
  • Melanoma
    Alex Eggermont (France)
  • Cutaneous lymphoma
    Reinhard Dummer (Switzerland)
  • Therapeutically relevant targets of cutaneous tumors
    Hensin Tsao (USA)
  • Take home messages Axel Hauschild (Germany)

15:30-16:00 | Coffee break

16:00-17:30 | Free oral commnunication
Chairs: Alexander Stratigos (Greece), Colin Fleming (Scotland), Laurent Misery (France)

17:30-18:30 | Opening Ceremony

18:30-20:00 | Satellite symposium MSD/Schering-Plough:
Selecting patients for adjuvant treatment for melanoma

Tuesday, 21 June 2011

08:30-10:00 | Plenary session: Primary prevention and early detection
of melanoma: hot topics today
Chairs: Luc Thomas (France), Hubert Pehamberger (Austria), Michael Binder (Austria)

  • EPIDERM: Results of an EU-project against skin cancer
    Eggert Stockfleth (Germany)
  • Sunbed and melanoma risk: myth or reality?
    Isabel Longo (Spain)
  • Euromelanoma: results of a pan European skin cancer prevention campaign
    Véronique Del Marmol (Belgium)
  • Photo protection, vitamin D: where we are today?
    Marjam Barysch (Switzerland)
  • Follow up strategies for Nevi: is it still of interest?
    Jean-Jacques Grob (France)
  • New concepts in nevogenesis
    Iris Zalaudek (Austria)
  • Take home messages Ketty Peris (Italy)

10:00-10:30 | Coffee break

10:30-11:00 | Guest Lecture
Chairs: Georg Weinlich (Austria), Isabel Longo (Spain)

  • Genetic bases of human pigmentation: hope for new treatments? Richard A. Sturm (Australia)

11:00-12:30 | Plenary session: Melanoma management
Sponsored by MSD/Schering-Plough
Chairs: Josep Malvehy (Spain), Caroline Robert (France), Axel Hauschild (Germany)

  • Next staging classification?
    Jeffrey Gershenwald (United States)
  • New standards of pathology reporting
    Alain Spatz (Canada)
  • Biomarkers of interferon responsiveness useful in routine
    Helen Gogas (Greece)
  • Prognostic factors for sentinel lymph nodes and adjuvant treatment
    Vernon Sondak (United States)
  • An evidence based approach to excision margins of melanoma
    Philippe Saiag (France)
  • Take home messages Dirk Schadendorf (Germany)

12:30-14:00 | Lunch - Posters session

12:30-14:00 | Satellite symposium Bristol-Myers Squibb

14:00-15:30 | Free oral commnunications
Chairs: Alain Spatz (Canada), Peter Arenberger (Czech Republic), Marie-Françoise Avril (France)

15:30-16:00 | Coffee break

16:00-17:00 | Plenary session: Ongoing clinical trials
Chairs: Jerry Marsden (United Kingdom), Peter Hersey (Australia), Brigitte Dréno (France)

  • Melanoma
    Axel Hauschild (Germany)
  • Lymphoma
    Robert Knobler (Austria)
  • Non melanoma skin cancer
    Céleste Lebbé (France)
  • Take home messages John Kirkwood (United States)

17:00-18:30 | Satellite symposium Roche:
Advances in Skin Cancer - Finding a Tailored Solution for Patients


Wednesday, 22 June 2011

 

08:30-10:00 | Plenary session: Targeted therapy in melanoma: present and future
Chairs: Roland Kauffman (Germany), Helen Gogas (Greece), Philippe Saiag (France)

  • Monoclonal antibodies in melanoma
    John Kirkwood (United States)
  • Antigen specific immunotherapy
    Brigitte Dréno (France)
  • Targeted therapy
    Peter Hersey (Australia)
  • Anti angiogenic factors
    Hubert Pehamberger (Austria)
  • Cutaneous side effects and new drugs: how to manage?
    Caroline Robert (France)
  • Take home messages Claus Garbe (Germany)

10:00-10:30 | Coffee break

10:30-11:00 | Guest Lecture
Chairs: Giovanni Pellacini (Italy), Judith Olah (Hungary)

  • Innate Immunity and melanoma: current status and perspective
    Georg Stingl (Austria)

11:00-12:30 | Plenary session: Melanoma: from basic research to practice
Chairs: Céleste Lebbé (France), Reinhard Dummer (Switzerland), Dirk Schadendorf (Germany)

  • Outstanding questions in immunotherapy of melanoma
    Nathalie Labarrière (France)
  • Cells cultures and animal models in melanoma: new perspectives
    Jürgen Becker (Germany)
  • Human T cells responses against melanoma
    Pierre Coulie (Belgium)
  • Melanoma Genetic
    Julia Newton-Bishop (United-Kingdom)
  • Melanoma stem cell: still more questions than answers
    Lionel Larue (France)
  • Take home messages Georg Stingl (Austria)

12:30-14:00 | Lunch - Posters session

12:30-14:00 | Satellite symposium

14:00-15:30 | Free oral communications
Chairs: Georg Weinlich (Austria), Eggert Stockfleth (Germany), Marie-Thérèse Leccia (France)

15:30-16:00 | Coffee break

16:00-17:30 | Plenary session: Melanoma: imaging technique for our pratice in 2011
Chairs: Colin Morton (United Kingdom), Ketty Peris (Italy), Laurent Mortier (France)

  • Confocal Microscopy
    Giovanni Pellacini (Italy)
  • Dermoscopy
    Luc Thomas (France)
  • Ultrasound
    Alessandro Testori (Italy)
  • Telemedicine
    Alexander Stratigos (Greece)
  • From imaging to molecular biology
    Josep Malvehy (Spain)
  • Take home messages Jürgen Becker (Germany)

17:30-19:00 | Satellite symposium


Thursday, 23 June 2011

08:30-10:00 | Plenary session: Cutaneous lymphoma: managing cutaneous lymphoma in 2011
Chairs: Robert Knobler (Austria), Antonio Cozzio (Switzerland), Gaëlle Quéreux (France)

  • Molecular pathogenesis of CTCL: basis for a new classification?
    Sean Whittaker (United Kingdom)
  • Targeted therapy in cutaneous lymphoma: what does it means?
    Youn Kim (United States)
  • The optimal use of retinoids in Cutaneous T Cell Lymphomas
    Rudolph Stadler (Germany)
  • Management of Cutaneous B Cell Lymphomas
    Antonio Cozzio (Switzerland)
  • Management of CD30 + T Cell lymphoproliferative disorders?
    Marie Beylot (France)
  • Closing remarks Robert Knobler (Austria)

10:30-10:30 | Coffee break

10:30-12:10 | Plenary session: Non melanoma skin cancer: managing actinic keratosis
and carcinioma in 2011
Chairs: Colin Morton (United Kingdom), Alessandro Testori (Italy), Christophe Bédane (France)

  • Is there a genetic base for the concept of “field of cancerization”
    Antonio Costanzo (Italy)
  • Management of actinic keratosis
    Eggert Stockfleth (Germany)
  • Management of epithelial cell carcinomas in transplant patients
    Sylvie Euvrard (France)
  • New indications of PDT
    Colin Morton (United Kingdom)
  • Merkeloma and polyomavirus
    Olivier Dereure (France)
  • New hope for advanced non melanoma skin: targeted therapy
    Gregor Jemec (Denmark)
  • Closing remarks Selma Ugurel (Germany)

12h10 | Closing ceremony